Although these studies provide a better understanding of the role IP-10 plays in the development of NAFLD and its link to β cell destruction in diabetes, they provide limited information about the association between IP-10 and metabolic components. The gene discussed is CXCL10; the disease is metabolic dysfunction-associated steatotic liver disease.